| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 155, Issue 9 4376-4381, Copyright © 1995 by American Association of Immunologists
ARTICLES |
GT Spear, NS Lurain, CJ Parker, M Ghassemi, GH Payne and M Saifuddin
Department of Immunology/Microbiology, Rush Presbyterian-St. Luke's Medical Center, Chicago, IL 60612, USA.
The current study was undertaken to determine whether the human T cell leukemia/lymphoma oncovirus type I (HTLV-I) and the herpesvirus human cytomegalovirus (HCM) incorporate host cell-derived C regulatory proteins. Our experiments showed that both CD59 and CD55 were associated with the external membrane of HTLV-I derived from MT2 cells, since virus could be captured by mAbs to these proteins, and antisera to CD55 and CD59 induced C-mediated lysis of HTLV-I virions. Additionally, both CD55 and CD59 were detected by immunoblot analysis of purified HTLV-I. Purified HCMV produced in human foreskin fibroblasts (HFF) also contained both CD55 and CD59, as detected by immunoblot analysis. However, treatment with anti-CD55, but not anti- CD59, reduced the HCMV infectious titer in the presence of C. Additional studies determined whether HTLV-I-associated CD55 and CD59 participated in the resistance of the virus to C-mediated lysis. Treatment of virus with phosphatidylinositol-specific phospholipase C (PI-PLC), which removes glycosylphosphatidylinositol-anchored CD55 and CD59, increased the sensitivity of HTLV-I to C-mediated destruction in the presence of anti-HTLV-I Abs. Reconstitution of PI-PLC-treated virus with purified CD55 and CD59 restored resistance to C. These experiments show that HTLV-I and HCMV acquire C control proteins from host cells. Together with our previous experiments showing that both CD55 and CD59 are present on HIV-1, these studies demonstrate a mechanism by which a variety of enveloped viruses may acquire resistance to C-mediated destruction.
This article has been cited by other articles:
|
|
 |
|
  O. B. Spiller, L. Mark, C. E. Blue, D. G. Proctor, J. A. Aitken, A. M. Blom, and D. J. Blackbourn Dissecting the Regions of Virion-Associated Kaposi's Sarcoma-Associated Herpesvirus Complement Control Protein Required for Complement Regulation and Cell Binding. J. Virol., April 1, 2006; 80(8): 4068 - 4078. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-S. Chung, C.-H. Chen, M.-Y. Ho, C.-Y. Huang, C.-L. Liao, and W. Chang Vaccinia Virus Proteome: Identification of Proteins in Vaccinia Virus Intracellular Mature Virion Particles J. Virol., March 1, 2006; 80(5): 2127 - 2140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kolegraff, P. Bostik, and A. A. Ansari Characterization and role of lentivirus-associated host proteins. Experimental Biology and Medicine, March 1, 2006; 231(3): 252 - 263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Takemoto, M. Koike, Y. Mori, S. Yonemoto, Y. Sasamoto, K. Kondo, Y. Uchiyama, and K. Yamanishi Human Herpesvirus 6 Open Reading Frame U14 Protein and Cellular p53 Interact with Each Other and Are Contained in the Virion J. Virol., October 15, 2005; 79(20): 13037 - 13046. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Cantin, S. Methot, and M. J. Tremblay Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses J. Virol., June 1, 2005; 79(11): 6577 - 6587. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Johannsen, M. Luftig, M. R. Chase, S. Weicksel, E. Cahir-McFarland, D. Illanes, D. Sarracino, and E. Kieff Proteins of purified Epstein-Barr virus PNAS, November 16, 2004; 101(46): 16286 - 16291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ye, S. Jin, M. M. Ataai, J. S. Schultz, and J. Ibeh Tagging Retrovirus Vectors with a Metal Binding Peptide and One-Step Purification by Immobilized Metal Affinity Chromatography J. Virol., September 15, 2004; 78(18): 9820 - 9827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Allal, C. Buisson-Brenac, V. Marion, C. Claudel-Renard, T. Faraut, P. Dal Monte, D. Streblow, M. Record, and J.-L. Davignon Human Cytomegalovirus Carries a Cell-Derived Phospholipase A2 Required for Infectivity J. Virol., July 15, 2004; 78(14): 7717 - 7726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Magre, Y. Takeuchi, G. Langford, A. Richards, C. Patience, and R. Weiss Reduced Sensitivity to Human Serum Inactivation of Enveloped Viruses Produced by Pig Cells Transgenic for Human CD55 or Deficient for the Galactosyl-{alpha}(1-3) Galactosyl Epitope J. Virol., June 1, 2004; 78(11): 5812 - 5819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. T. Penfold, T. L. Schmidt, D. J. Dairaghi, P. A. Barry, and T. J. Schall Characterization of the Rhesus Cytomegalovirus US28 Locus J. Virol., October 1, 2003; 77(19): 10404 - 10413. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Huemer, C. Wechselberger, A. M. Bennett, D. Falke, and L. Harrington Cloning and expression of the complement receptor glycoprotein C from Herpesvirus simiae (herpes B virus): protection from complement-mediated cell lysis J. Gen. Virol., May 1, 2003; 84(5): 1091 - 1100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Pausa, V. Pellis, M. Cinco, P. G. Giulianini, G. Presani, S. Perticarari, R. Murgia, and F. Tedesco Serum-Resistant Strains of Borrelia burgdorferi Evade Complement-Mediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule J. Immunol., March 15, 2003; 170(6): 3214 - 3222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Homman-Loudiyi, K. Hultenby, W. Britt, and C. Soderberg-Naucler Envelopment of Human Cytomegalovirus Occurs by Budding into Golgi-Derived Vacuole Compartments Positive for gB, Rab 3, Trans-Golgi Network 46, and Mannosidase II J. Virol., March 1, 2003; 77(5): 3191 - 3203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Favoreel, G. R. Van de Walle, H. J. Nauwynck, and M. B. Pensaert Virus complement evasion strategies J. Gen. Virol., January 1, 2003; 84(1): 1 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. B. Spiller, M. Robinson, E. O'Donnell, S. Milligan, B. P. Morgan, A. J. Davison, and D. J. Blackbourn Complement Regulation by Kaposi's Sarcoma-Associated Herpesvirus ORF4 Protein J. Virol., December 6, 2002; 77(1): 592 - 599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Takefman, G. T. Spear, M. Saifuddin, and C. A. Wilson Human CD59 Incorporation into Porcine Endogenous Retrovirus Particles: Implications for the Use of Transgenic Pigs for Xenotransplantation J. Virol., February 15, 2002; 76(4): 1999 - 2002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Klein, K. Schoppel, N. Amvrossiadis, and M. Mach Strain-Specific Neutralization of Human Cytomegalovirus Isolates by Human Sera J. Virol., February 1, 1999; 73(2): 878 - 886. [Abstract] [Full Text]
|
|
|
|
|
|
A. Gallina, L. Simoncini, S. Garbelli, E. Percivalle, G. Pedrali-Noy, K. S. Lee, R. L. Erikson, B. Plachter, G. Gerna, and G. Milanesi Polo-Like Kinase 1 as a Target for Human Cytomegalovirus pp65 Lower Matrix Protein J. Virol., February 1, 1999; 73(2): 1468 - 1478. [Abstract] [Full Text]
|
|
|
|
|
|
F. Ikeda, Y. Haraguchi, A. Jinno, Y. Iino, Y. Morishita, H. Shiraki, and H. Hoshino Human Complement Component C1q Inhibits the Infectivity of Cell-Free HTLV-I J. Immunol., November 15, 1998; 161(10): 5712 - 5719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Bodaghi, T. R. Jones, D. Zipeto, C. Vita, L. Sun, L. Laurent, F. Arenzana-Seisdedos, J.-L. Virelizier, and S. Michelson Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells J. Exp. Med., September 7, 1998; 188(5): 855 - 866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Balliet and P. Bates Efficient Infection Mediated by Viral Receptors Incorporated into Retroviral Particles J. Virol., January 1, 1998; 72(1): 671 - 676. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
